DEVELOPMENT AND OPTIMIZATION OF TERIFLUNOMIDE-LOADED CHONDROITIN SULPHATE-COATED NANOSTRUCTURED LIPID CARRIERS (NLCS) THROUGH BOX BEHNKEN DESIGN

被引:0
作者
Campos, Cristobal [1 ]
Torres-Vergara, Pablo [1 ]
Godoy, Ricardo [1 ]
Riquelme, Cristina [1 ]
Arellano-Villasenor, Noemi [2 ]
Chavez-Santoscoy, Rocio alejandra [3 ]
Herbas-Goitia, Isabel [1 ]
Gomez-gaete, Carolina [1 ]
机构
[1] Univ Concepcion, Fac Farm, Dept Farm, Concepcion, Chile
[2] Univ Autonoma Baja California Campus, Fac Ciencias Quim Ingn, Tijuana, Mexico
[3] Sch Engn & Sci, Tecnol Monterrey, Monterrey 64849, Mexico
关键词
Teriflunomide; rheumatoid arthritis; nanostructured lipid carrier; experiment design; IN-VITRO; RHEUMATOID-ARTHRITIS; INTRANASAL DELIVERY; RISK-ASSESSMENT; ORAL DELIVERY; NANOPARTICLES; ACID; FORMULATION; SYSTEM; LEFLUNOMIDE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Rheumatoid arthritis (RA) is an autoimmune chronic disease characterized by disabling pain and deformity of the joints. Teriflunomide (TFM), a metabolite from leflunomide, is given orally to RA patients, but its gastrointestinal and systemic side effects are severe and not well tolerated. This study aims to optimize and develop nanostructured lipid carriers (NLC) loaded with teriflunomide (NLC-TFM). NLCs were developed by homogenization and ultrasound. The optimization parameters were achieved through a Box-Behnken experimental design. The optimized NLC-TFM were also coated with chondroitin sulfate (NLC-TFM-CHS) to enhance its interaction with target tissues and shift its focus to intra-articular administration. Both formulations were characterized in their morphology, particle size (PS), Zeta potential, entrapment efficiency (EE%), drug loading (DL%), molecular interactions and in vitro release kinetics. The developed NLC-TFM and NLC-TFM-CHS exhibited a spherical morphology, Zeta potential lower than -30 mV, mean PS of 178.6-211 nm, EE% of 85.95-65.78 % and DL% of 3.97-2.97%, respectively. Thermal and crystalline behavior analyses suggested that TFM is dissolved within the lipidic matrix. The release of TFM showed a biphasic pattern, with an initial burst release followed by a sustained release, being the latter more marked in NLC-TFM-CHS. The developed formulations show promise as delivery systems for targeted therapy of RA through intra-articular administration.
引用
收藏
页码:5832 / 5838
页数:7
相关论文
共 50 条
[31]   Development Optimization and Cytotoxicity Evaluation of Glyburide Loaded Nanostructured Lipid Carriers [J].
Ashwini, M. ;
Sudheer, Preethi ;
Sogali, Bharani S. ;
Chandramouli, R. .
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (02) :S189-S199
[32]   Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells [J].
Costa, C. P. ;
Cunha, S. ;
Moreira, J. N. ;
Silva, R. ;
Gil-Martins, E. ;
Silva, V. ;
Azevedo, L. ;
Peixoto, A. F. ;
Lobo, J. M. Sousa ;
Silva, A. C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 607
[33]   Intradermal delivery of nanohybrid thermosensitive hydrogels loaded with chondroitin sulphate coated pomegranate lipid carriers via hollow microneedles for effective rheumatoid arthritis management [J].
Zewail, Mariam ;
Abbas, Haidy ;
El Sayed, Nesrine ;
Newehy, Nihal M. El ;
Abd-El-Azim, Heba .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 112
[34]   Box Behnken Design-Enabled Development of Nanostructured Lipid Carrier Transdermal Patch for Enhancement of Bioavailability of Olmesartan Medoxomil [J].
Sahoo, Laxmidhar ;
Jena, Goutam Kumar ;
Patro, Chandra Sekhar ;
Patro, Ch Niranjan ;
Satapathy, Sukanta .
JOURNAL OF PHARMACEUTICAL INNOVATION, 2022, 17 (04) :1405-1419
[35]   Thymoquinone loaded dermal lipid nano particles: Box Behnken design optimization to preclinical psoriasis assessment [J].
Ali, Asgar ;
Ali, Salman ;
Aqil, Mohd ;
Imam, Syed Sarim ;
Ahad, Abdul ;
Qadir, Abdul .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 52 :713-721
[36]   Optimization of Tilmicosin-Loaded Nanostructured Lipid Carriers Using Orthogonal Design for Overcoming Oral Administration Obstacle [J].
Wen, Jia ;
Gao, Xiuge ;
Zhang, Qian ;
Sahito, Benazir ;
Si, Hongbin ;
Li, Gonghe ;
Ding, Qi ;
Wu, Wenda ;
Nepovimova, Eugenie ;
Jiang, Shanxiang ;
Wang, Liping ;
Kuca, Kamil ;
Guo, Dawei .
PHARMACEUTICS, 2021, 13 (03) :1-17
[37]   Design, development and characterization of Papain-loaded nanostructured lipid carriers for enhanced stability and bio-accessibility in acidic environments [J].
Chandan, C. ;
Kumar, G. Phani ;
Jawahar, N. ;
Sushma, B. V. ;
Amachawadi, Raghavendra G. ;
Shati, Ali A. ;
Alfaifi, Mohammad Y. ;
Elbehairi, Serag Eldin I. ;
Prasad, Shashanka K. ;
Shivamallu, Chandan ;
Jeyaprakash, M. R. ;
Kollur, Shiva Prasad .
RESULTS IN CHEMISTRY, 2024, 8
[38]   Formulation of chrysin loaded nanostructured lipid carriers using Box Behnken design, its characterization and antibacterial evaluation alone and in presence of probiotics co-loaded in gel [J].
Parveen, Shaik Rahana ;
Wadhwa, Sheetu ;
Babu, Molakpogu Ravindra ;
Vishwas, Sukriti ;
Corrie, Leander ;
Awasthi, Ankit ;
Khan, Farhan R. ;
Al-Bazi, Maha M. ;
Alharthi, Nahed S. ;
Alotaibi, Faisal ;
Gupta, Gaurav ;
Pandey, Narendra Kumar ;
Kumar, Bimlesh ;
Kumbhar, Popat ;
Disouza, John ;
Gulati, Monica ;
Neelamraju, Jayanthi ;
Madempudi, Ratna Sudha ;
Dua, Kamal ;
Singh, Sachin Kumar .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 84
[39]   Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design [J].
Agrawal, Mukta ;
Saraf, Shailendra ;
Pradhan, Madhulika ;
Patel, Ravish J. ;
Singhvi, Gautam ;
Ajazuddin ;
Alexander, Amit .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
[40]   Box-Behnken Design Optimization of Etoposide Loaded Nanoemulsion: Formulation Development, Cellular Uptake Analysis and Pharmacokinetic Evaluation [J].
Mahato, Mrigendra ;
Anil, Sukumaran ;
Mahmoud, Mohamed H. ;
Mir, Showkat R. ;
Fouad, H. ;
Ameen, Sadia ;
Amin, Saima .
SCIENCE OF ADVANCED MATERIALS, 2021, 13 (09) :1797-1806